Prostate Cancer Misdiagnosis Elimination Act of 2017
This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
Actions
Nov 2, 2017
Read twice and referred to the Committee on Finance.